☆ 4.7 Article

Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population-based cohort study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Related references

Note: Only part of the references are listed.

Article Surgery

Metachronous gastric neoplasm beyond 5 years after endoscopic resection for early gastric cancer

Eunwoo Lee et al.

Summary: This study aimed to clarify the long-term clinical outcomes and risk factors of metachronous gastric neoplasm (MGN) 5 years after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). The study found that male sex, severe intestinal metaplasia, tumor-positive lateral margin, <5 mm lateral safety margin, and synchronous adenoma were positive predictive factors for MGN after 5 years post-ESD. In addition, successful eradication of Helicobacter pylori was a negative predictive factor for MGN.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2023)

Add to Collection

Article Gastroenterology & Hepatology

Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States

Dan Li et al.

Summary: This large-scale retrospective cohort study in the United States investigated the incidence of noncardia gastric adenocarcinoma (NCGA) after Helicobacter pylori eradication therapy. The findings showed a significantly reduced risk of NCGA after 8 years of treatment compared to no treatment. This study highlights the potential for substantial gastric cancer prevention through H pylori eradication. Evaluation: 8 out of 10.

GASTROENTEROLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Meta-analysis: Use of proton pump inhibitors and risk of gastric cancer in patients requiring gastric acid suppression

Daniele Piovani et al.

Summary: This study systematically searched and analyzed randomized and non-randomized studies to assess the risk of gastric cancer associated with the use of proton-pump inhibitors (PPIs). The results showed no association between PPIs and gastric cancer, especially based on non-randomized studies.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Add to Collection

Review Gastroenterology & Hepatology

Risk factors for gastric metachronous lesions after endoscopic or surgical resection: a systematic review and meta-analysis

Raquel Ortigao et al.

Summary: This study conducted a systematic review of 52 studies to identify risk factors for metachronous gastric lesions (MGL) and compare the incidence after endoscopic resection (ER) and subtotal gastrectomy. The results showed that the incidence of MGL after ER was significantly higher than after subtotal gastrectomy. Factors such as age, sex, family history, synchronous lesions, gastric mucosal atrophy, intestinal metaplasia, H. pylori infection, and pepsinogen I/II ratio were significantly associated with MGL after ER. The study highlights the importance of individualized follow-up schedules based on different surgical procedures and risk factors.

ENDOSCOPY (2022)

Add to Collection

Letter Gastroenterology & Hepatology

Evaluation of proton pump inhibitors and risks of gastric cancer

Ruijie Zeng et al.

GUT (2022)

Add to Collection

Article Health Care Sciences & Services

Immortal time bias for life-long conditions in retrospective observational studies using electronic health records

Freya Tyrer et al.

Summary: This study investigated immortal time bias for a specific life-long condition, intellectual disability, using the Clinical Practice Research Datalink (CPRD). The results show that immortal time bias is a significant issue for studies of life-long conditions that use electronic health record data and careful consideration of clinical diagnoses entry is needed.

BMC MEDICAL RESEARCH METHODOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Proton pump inhibitors and risk of gastric cancer: population-based cohort study

Devin Abrahami et al.

Summary: The study found that the use of PPIs is associated with an increased risk of gastric cancer compared with the use of H2RAs, although the absolute risk remains low.

GUT (2022)

Add to Collection

Article Gastroenterology & Hepatology

Association of Proton Pump Inhibitor Use With All-Cause and Cause-Specific Mortality

Chun-Han Lo et al.

Summary: This study suggests that the use of PPIs is not associated with an increased risk of all-cause mortality and mortality due to major causes after accounting for protopathic bias.

GASTROENTEROLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

Peter Malfertheiner et al.

Summary: Helicobacter pylori infection is recognized as an infectious disease and requires optimized management to prevent complications and gastric cancer. Continuous updates in treatment strategies and testing methods are necessary due to rising antibiotic resistance and the impact on gut microbiota.

GUT (2022)

Add to Collection

Article Oncology

Use of Proton Pump Inhibitors and the Risk for the Development of Gastric Cancers: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions

Eun Jeong Gong et al.

Summary: Previous cohort studies using national claim data in Korea have shown conflicting results about the association between the use of proton pump inhibitors (PPIs) and the risk of gastric cancer. This study aimed to evaluate the association between PPI use and the risk of gastric cancer using balanced operational definitions, and found no increased risk.

CANCERS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study

Ga-Yeong Shin et al.

Summary: A population-based cohort study in Korea found no increased risk of gastric cancer with long-term use of PPIs compared to H2RAs, even in a high-risk region.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea

Seung In Seo et al.

Summary: This study aimed to evaluate the association between proton pump inhibitor (PPI) use and gastric cancer in a high-risk region like Korea. The results showed that PPI use was associated with an increased incidence of gastric cancer, regardless of Helicobacter pylori eradication status. Long-term use of PPI should be approached with caution in high-risk regions for gastric cancer.

GUT (2021)

Add to Collection

Review Gastroenterology & Hepatology

When does proton pump inhibitor treatment become long term? A scoping review

Peter Fentz Haastrup et al.

Summary: The definition of long-term PPI treatment varied substantially between studies and were seldom rationalized. In a clinical context, the definition may vary depending on the patient's condition. For research purposes, a tailored definition may be necessary depending on the study's objectives. It is recommended to always rationalize the choice of definition.

BMJ OPEN GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment

Hirotaka Oura et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population

Jeffrey K. Lee et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection

Article Oncology

Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies

Peipei Liu et al.

BRITISH JOURNAL OF CANCER (2020)

Add to Collection

Article Gastroenterology & Hepatology

Impact of the timing of Helicobacter pylori eradication on the risk of development of metachronous lesions after treatment of early gastric cancer: a population-based cohort study

Hyun Ju Kim et al.

GASTROINTESTINAL ENDOSCOPY (2020)

Add to Collection

Review Endocrinology & Metabolism

Data Configuration and Publication Trends for the Korean National Health Insurance and Health Insurance Review & Assessment Database

Hae Kyung Kim et al.

DIABETES & METABOLISM JOURNAL (2020)

Add to Collection

Article Gastroenterology & Hepatology

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

Paul Moayyedi et al.

GASTROENTEROLOGY (2019)

Add to Collection

Letter Gastroenterology & Hepatology

Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis

Ryota Niikura et al.

GUT (2018)

Add to Collection

Article Gastroenterology & Hepatology

Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study

Ka Shing Cheung et al.

GUT (2018)

Add to Collection

Article Gastroenterology & Hepatology

Novel risk stratification for metachronous recurrence after curative endoscopic submucosal dissection for early gastric cancer

Hyo-Joon Yang et al.

GASTROINTESTINAL ENDOSCOPY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial

Ji Min Choi et al.

GASTROINTESTINAL ENDOSCOPY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Long-Term Clinical Outcomes of Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Prospective Multicenter Cohort Study

Sang Gyun Kim et al.

GUT AND LIVER (2018)

Add to Collection

Article Medicine, General & Internal

Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer

Il Ju Choi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Review Gastroenterology & Hepatology

The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association

Daniel E. Freedberg et al.

GASTROENTEROLOGY (2017)

Add to Collection

Review Gastroenterology & Hepatology

25 Years of Proton Pump Inhibitors: A Comprehensive Review

Daniel S. Strand et al.

GUT AND LIVER (2017)

Add to Collection

Article Gastroenterology & Hepatology

Factors Associated With Metachronous Gastric Cancer Development After Endoscopic Submucosal Dissection for Early Gastric Cancer

Reiko Ami et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden

Nele Brusselaers et al.

BMJ OPEN (2017)

Add to Collection

Editorial Material Gastroenterology & Hepatology

We Are Using Too Many PPIs, and We Need to Stop: A European Perspective

Angel Lanas

AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study

Jeung Hui Pyo et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)

Add to Collection

Review Gastroenterology & Hepatology

Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology

L. Lundell et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)

Add to Collection

Review Gastroenterology & Hepatology

Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition

Sang Gyun Kim et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)

Add to Collection

Article Endocrinology & Metabolism

Background and Data Configuration Process of a Nationwide Population-Based Study Using the Korean National Health Insurance System

Sun Ok Song et al.

DIABETES & METABOLISM JOURNAL (2014)

Add to Collection

Article Oncology

Proton pump inhibitors and risk of gastric cancer: a population-based cohort study

A. H. Poulsen et al.

BRITISH JOURNAL OF CANCER (2009)

Add to Collection

Article Public, Environmental & Occupational Health

Immortal time bias in pharmacoepidemiology

Samy Suissa

AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)

Add to Collection

Article Public, Environmental & Occupational Health

Association between use of acid-suppressive drugs and risk of gastric cancer - A nested case-control study

Hani Tamim et al.

DRUG SAFETY (2008)

Add to Collection

Article Medicine, General & Internal

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer:: an open-label, randomised controlled trial

Kazutoshi Fukase et al.

LANCET (2008)

Add to Collection

Article Gastroenterology & Hepatology

Proton pump inhibitors and gastric neoplasia

E. J. Kuipers

GUT (2006)

Add to Collection

Article Health Care Sciences & Services

New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality

V Sundararajan et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.